1. Home
  2. PI vs APLS Comparison

PI vs APLS Comparison

Compare PI & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PI
  • APLS
  • Stock Information
  • Founded
  • PI 2000
  • APLS 2009
  • Country
  • PI United States
  • APLS United States
  • Employees
  • PI N/A
  • APLS N/A
  • Industry
  • PI Industrial Machinery/Components
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PI Technology
  • APLS Health Care
  • Exchange
  • PI Nasdaq
  • APLS Nasdaq
  • Market Cap
  • PI 1.9B
  • APLS 2.2B
  • IPO Year
  • PI 2016
  • APLS 2017
  • Fundamental
  • Price
  • PI $103.57
  • APLS $17.69
  • Analyst Decision
  • PI Buy
  • APLS Buy
  • Analyst Count
  • PI 7
  • APLS 19
  • Target Price
  • PI $141.71
  • APLS $37.67
  • AVG Volume (30 Days)
  • PI 397.4K
  • APLS 2.1M
  • Earning Date
  • PI 07-23-2025
  • APLS 07-31-2025
  • Dividend Yield
  • PI N/A
  • APLS N/A
  • EPS Growth
  • PI N/A
  • APLS N/A
  • EPS
  • PI N/A
  • APLS N/A
  • Revenue
  • PI $363,539,000.00
  • APLS $775,839,000.00
  • Revenue This Year
  • PI N/A
  • APLS $1.01
  • Revenue Next Year
  • PI $25.60
  • APLS $22.14
  • P/E Ratio
  • PI N/A
  • APLS N/A
  • Revenue Growth
  • PI 21.80
  • APLS 48.04
  • 52 Week Low
  • PI $60.85
  • APLS $16.10
  • 52 Week High
  • PI $239.88
  • APLS $42.47
  • Technical
  • Relative Strength Index (RSI)
  • PI 41.59
  • APLS 42.98
  • Support Level
  • PI $104.00
  • APLS $18.26
  • Resistance Level
  • PI $108.75
  • APLS $19.96
  • Average True Range (ATR)
  • PI 4.70
  • APLS 0.84
  • MACD
  • PI -2.31
  • APLS -0.08
  • Stochastic Oscillator
  • PI 9.76
  • APLS 19.22

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: